On October 3, 2017 Roche (SIX: RO, ROG; OTCQX:RHHBY), reported the launch of the NAVIFY Tumor Board solution, a clinical workflow and decision support software that optimises decision-making for cancer patient case reviews in tumor boards, or multi-disciplinary team meetings (Press release, Hoffmann-La Roche, OCT 3, 2017, View Source [SID1234520752]). The solution fundamentally changes the way these meetings are organised and conducted. It is initially available in the US, UK, Germany, Spain, Sweden, and Switzerland.
Tumor board coordination is labour intensive and time consuming for health care providers with patients’ medical history, biomarkers, tumor information, radiology images, microscope slide images, pathology reports, and electronic medical record notes frequently having to be collected and organised manually.
The new NAVIFY Tumor Board solution streamlines and standardizes workflows by aggregating relevant patient data from these disparate sources into a workflow software solution that facilitates efficient team collaboration, reduces errors, and gives the care team more time to evaluate potential treatment options.
To facilitate interaction, the NAVIFY Tumor Board solution also allows remote participation of experts from outside the location during the meeting.
“Oncology care teams are now able to collaborate on the review of patient cases and tailor treatments to the individual with a higher degree of confidence and more efficiently,” said Roland Diggelmann, Chief Executive Officer, Roche Diagnostics. “At Roche, we are passionate about personalised healthcare and providing decision support that helps ensure that all available data is used to accelerate and optimise patient care.”
About NAVIFY
Roche Diagnostics is launching the NAVIFY brand demonstrating its commitment to provide healthcare professionals with digital decision support solutions that transform patient care. The NAVIFY portfolio’s first product is the NAVIFY Tumor Board solution, being launched. The portfolio will in the near future, evolve rapidly to include additional decision support applications and workflow products that address challenges faced by healthcare providers as well as research and development applications.
Patient data security and privacy are of the highest priority for Roche. The NAVIFY Tumor Board solution is built on a secure cloud platform that is HIPAA compliant.